These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9579831)

  • 21. Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells.
    Kim MR; Park DW; Lee JH; Choi DS; Hwang KJ; Ryu HS; Min CK
    Mol Hum Reprod; 2005 Nov; 11(11):801-8. PubMed ID: 16403803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of beta1 integrin expression in the physio/pathological states of human endometrial tissues.
    Moro L; Greco M; Maiorano E; Selvaggi L; Marra E; Perlino E
    Int J Oncol; 2005 Feb; 26(2):457-65. PubMed ID: 15645131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.
    Yu N; Kozlowski JM; Park II; Chen L; Zhang Q; Xu D; Doll JA; Crawford SE; Brendler CB; Lee C
    Urology; 2010 Dec; 76(6):1519.e8-13. PubMed ID: 21030067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma.
    Ananth S; Knebelmann B; Grüning W; Dhanabal M; Walz G; Stillman IE; Sukhatme VP
    Cancer Res; 1999 May; 59(9):2210-6. PubMed ID: 10232610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
    Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
    Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor.
    Jung CW; Kim ES; Seol JG; Park WH; Lee SJ; Kim BK; Lee YY
    Leuk Res; 1999 Dec; 23(12):1105-12. PubMed ID: 10613355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
    De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.
    Mhawech-Fauceglia P; Kesterson J; Wang D; Akers S; DuPont NC; Clark K; Lele S; Liu S
    Histopathology; 2011 Jul; 59(1):63-72. PubMed ID: 21771027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.
    Bristow RE; Baldwin RL; Yamada SD; Korc M; Karlan BY
    Cancer; 1999 Feb; 85(3):658-68. PubMed ID: 10091739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
    Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites.
    Chegini N; Zhao Y; Williams RS; Flanders KC
    Endocrinology; 1994 Jul; 135(1):439-49. PubMed ID: 8013382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
    Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH
    Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of transforming growth factor-beta (TGF beta) isoforms and TGF beta type II receptor messenger ribonucleic acid and protein, and the effect of TGF beta s on endometrial stromal cell growth and protein degradation in vitro.
    Tang XM; Zhao Y; Rossi MJ; Abu-Rustum RS; Ksander GA; Chegini N
    Endocrinology; 1994 Jul; 135(1):450-9. PubMed ID: 8013384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
    Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta 1C Integrin expression in human endometrial proliferative diseases.
    Lovecchio M; Maiorano E; Vacca RA; Loverro G; Fanelli M; Resta L; Stefanelli S; Selvaggi L; Marra E; Perlino E
    Am J Pathol; 2003 Dec; 163(6):2543-53. PubMed ID: 14633626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.